The Food and Drug Administration on Tuesday posted a warning about generic forms of a popular hair-loss medication often sold ...

Commissioner Marty Makary said he has no plans to change current policy to restrict access to the abortion pill mifepristone, ...

According to the FDA, they have not received official approval, and no comprehensive safety data has been submitted for them.

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...

FDA warning on topical finasteride: The FDA issued a warning about the topical form of finasteride (generic Propecia), often ...

Sen. Josh Hawley said it is "extremely disappointing" that FDA Commissioner Dr. Marty Makary has "no plans" for abortion ...

A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left ...

Since the reversal of Roe v. Wade, the number of abortions is up because of telehealth and the free sharing of mifepristone ...

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

Eli Lilly (NYSE:LLY) has filed lawsuits against four telehealth platforms that the pharma giant alleges are selling ...

Hims & Hers Health (HIMS) stock declined about 2% yesterday. The fall came after the U.S. Food and Drug Administration (FDA) ...